Astria Therapeutics Inc
(ATXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATXS | AZN | AMGN | GILD | BMY |
| Company | Astria Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 12.48 | 190.46 | 369.99 | 149.69 | 60.00 |
| High | 12.59 | 191.39 | 377.00 | 150.60 | 61.86 |
| Low | 12.45 | 188.49 | 368.90 | 148.71 | 59.77 |
| Latest | 12.58 | 191.40 | 376.10 | 151.26 | 61.58 |
| Change | +0.08 | +4.24 | +8.30 | +1.89 | +2.06 |
| % Change | +0.64% | +2.27% | +2.26% | +1.27% | +3.46% |
| Volume | 3,199,300 | 1,041,689 | 664,268 | 2,430,316 | 5,467,226 |
| 20-Day Average Volume | 800,220 | 4,728,228 | 2,924,509 | 7,844,977 | 12,870,632 |
| Previous Close | 12.50 | 187.16 | 367.80 | 149.37 | 59.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 12.81 | 186.98 | 342.57 | 134.38 | 55.97 |
| 20-Day Raw Stochastic | 32.54% | 81.80% | 95.46% | 98.11% | 96.79% |
| 20-Day Relative Strength | 49.91 | 56.00 | 68.77 | 75.38 | 72.88 |
| Weighted Alpha | +47.99 | +36.64 | +36.35 | +62.39 | +22.47 |
| Today's Opinion | 56% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 56% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 96% Buy | 100% Buy | 96% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.32% since 01/14/26 | +2.50% since 01/30/26 | +9.49% since 01/30/26 | +5.61% since 01/30/26 | +11.78% since 01/30/26 |
| Low | 12.24 on 01/20/26 | 183.63 on 02/03/26 | 338.59 on 02/03/26 | 140.01 on 02/02/26 | 54.96 on 02/02/26 |
| High | 12.85 on 01/15/26 | 192.79 on 02/02/26 | 376.91 on 02/06/26 | 150.50 on 02/05/26 | 61.80 on 02/06/26 |
| 1-Month | |||||
| %Chg | -2.63% since 12/22/25 | +0.13% since 01/06/26 | +13.37% since 01/06/26 | +23.53% since 01/06/26 | +13.07% since 01/06/26 |
| Low | 12.24 on 01/20/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 13.28 on 01/07/26 | 193.02 on 01/07/26 | 376.91 on 02/06/26 | 150.50 on 02/05/26 | 61.80 on 02/06/26 |
| 3-Month | |||||
| %Chg | +3.03% since 10/22/25 | +13.51% since 11/06/25 | +18.61% since 11/06/25 | +21.48% since 11/06/25 | +31.96% since 11/06/25 |
| Low | 12.11 on 11/04/25 | 168.44 on 11/07/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 13.29 on 12/04/25 | 193.02 on 01/07/26 | 376.91 on 02/06/26 | 150.50 on 02/05/26 | 61.80 on 02/06/26 |
| 6-Month | |||||
| %Chg | +95.95% since 07/22/25 | +29.19% since 08/06/25 | +31.49% since 08/06/25 | +35.94% since 08/06/25 | +37.29% since 08/06/25 |
| Low | 6.06 on 08/11/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 13.29 on 12/04/25 | 193.02 on 01/07/26 | 376.91 on 02/06/26 | 150.50 on 02/05/26 | 61.80 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 718,129 | 290,267,936 | 198,053,312 | 185,320,384 | 121,168,016 |
| Shares Outstanding, K | 57,085 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -94,260,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 710,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -31,640,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 0.01 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 11/12/25 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/10/26 | 02/10/26 | 05/07/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.51 | 16.76 | 17.85 | 8.78 |